Jerez Izquierdo Tamara1, Gómez Rivas Juan2, Zondervan Jeannelle Patricia3, Vives Dilme Roser2, Rodriguez Moisés4, Enikeev Dmitry5, Serrano Pascual Álvaro2, Moreno Sierra Jesús2. 1. Hospital Clínico San Carlos, Complutense, University of Madrid, Madrid, Spain. tamarajerez@outlook.es. 2. Hospital Clínico San Carlos, Complutense, University of Madrid, Madrid, Spain. 3. Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands. 4. ICUA (Instituto de Cirugía Urológica Avanzada), Madrid, Spain. 5. Institute for Urology and Reproductive Health, Cechenov University, Moscow, Russian Federation.
Abstract
PURPOSE OF REVIEW: To present an overview of the current evidence-based studies covering diagnostic and management of SRM. RECENT FINDINGS: Renal cell carcinoma (RCC) represents 3% of the cancers. Nowadays, partial nephrectomy (PN) represents gold standard treatment. New nephron-sparing approaches such as active surveillance and ablative therapies have been increasingly used as an alternative to surgical intervention. Due to novel comprehension of RCC and widespread use of imaging techniques, diagnosis at early stage in elderly patients has increased. Treatment decision-making should be based on patient and tumour characteristics. With expanding treatment options, the management of SRMs has become a debate and should be adjusted to patient and tumour characteristics. In a shared decision manner, both active surveillance with possible delayed intervention and focal therapy should be discussed with the patient as an alternative to partial nephrectomy.
PURPOSE OF REVIEW: To present an overview of the current evidence-based studies covering diagnostic and management of SRM. RECENT FINDINGS: Renal cell carcinoma (RCC) represents 3% of the cancers. Nowadays, partial nephrectomy (PN) represents gold standard treatment. New nephron-sparing approaches such as active surveillance and ablative therapies have been increasingly used as an alternative to surgical intervention. Due to novel comprehension of RCC and widespread use of imaging techniques, diagnosis at early stage in elderly patients has increased. Treatment decision-making should be based on patient and tumour characteristics. With expanding treatment options, the management of SRMs has become a debate and should be adjusted to patient and tumour characteristics. In a shared decision manner, both active surveillance with possible delayed intervention and focal therapy should be discussed with the patient as an alternative to partial nephrectomy.
Authors: John M Hollingsworth; David C Miller; Stephanie Daignault; Brent K Hollenbeck Journal: J Natl Cancer Inst Date: 2006-09-20 Impact factor: 13.506
Authors: Alberto Breda; Eric G Treat; Leah Haft-Candell; John T Leppert; Jonathan D Harper; Jonathan Said; Steven Raman; Robert B Smith; Arie S Belldegrun; Peter G Schulam Journal: BJU Int Date: 2009-11-02 Impact factor: 5.588
Authors: Igor Frank; Michael L Blute; John C Cheville; Christine M Lohse; Amy L Weaver; Horst Zincke Journal: J Urol Date: 2003-12 Impact factor: 7.450
Authors: Alexander Kutikov; Brian L Egleston; Daniel Canter; Marc C Smaldone; Yu-Ning Wong; Robert G Uzzo Journal: J Urol Date: 2012-10-18 Impact factor: 7.450